Style | Citing Format |
---|---|
MLA | Wan H, et al.. "Effect of Survodutide, a Glucagon and Glp-1 Receptor Dual Agonist, on Weight Loss: A Meta-Analysis of Randomized Controlled Trials." Diabetology and Metabolic Syndrome, vol. 16, no. 1, 2024, pp. -. |
APA | Wan H, Xu N, Wang L, Liu Y, Fatahi S, Sohouli MH, Guimaraes NS (2024). Effect of Survodutide, a Glucagon and Glp-1 Receptor Dual Agonist, on Weight Loss: A Meta-Analysis of Randomized Controlled Trials. Diabetology and Metabolic Syndrome, 16(1), -. |
Chicago | Wan H, Xu N, Wang L, Liu Y, Fatahi S, Sohouli MH, Guimaraes NS. "Effect of Survodutide, a Glucagon and Glp-1 Receptor Dual Agonist, on Weight Loss: A Meta-Analysis of Randomized Controlled Trials." Diabetology and Metabolic Syndrome 16, no. 1 (2024): -. |
Harvard | Wan H et al. (2024) 'Effect of Survodutide, a Glucagon and Glp-1 Receptor Dual Agonist, on Weight Loss: A Meta-Analysis of Randomized Controlled Trials', Diabetology and Metabolic Syndrome, 16(1), pp. -. |
Vancouver | Wan H, Xu N, Wang L, Liu Y, Fatahi S, Sohouli MH, et al.. Effect of Survodutide, a Glucagon and Glp-1 Receptor Dual Agonist, on Weight Loss: A Meta-Analysis of Randomized Controlled Trials. Diabetology and Metabolic Syndrome. 2024;16(1):-. |
BibTex | @article{ author = {Wan H and Xu N and Wang L and Liu Y and Fatahi S and Sohouli MH and Guimaraes NS}, title = {Effect of Survodutide, a Glucagon and Glp-1 Receptor Dual Agonist, on Weight Loss: A Meta-Analysis of Randomized Controlled Trials}, journal = {Diabetology and Metabolic Syndrome}, volume = {16}, number = {1}, pages = {-}, year = {2024} } |
RIS | TY - JOUR AU - Wan H AU - Xu N AU - Wang L AU - Liu Y AU - Fatahi S AU - Sohouli MH AU - Guimaraes NS TI - Effect of Survodutide, a Glucagon and Glp-1 Receptor Dual Agonist, on Weight Loss: A Meta-Analysis of Randomized Controlled Trials JO - Diabetology and Metabolic Syndrome VL - 16 IS - 1 SP - EP - PY - 2024 ER - |